Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
staccato fentanyl (AZ-003) / Ferrer International
NCT05531422: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP	Completed	2	60	RoW	Inhaled fentanyl aerosol, Placebo	Lee's Pharmaceutical Limited	Breakthrough Cancer Pain	03/23	04/23
NCT04713189: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain	Not yet recruiting	1/2	96	NA	Inhaled fentanyl aerosol, Placebo	Lee's Pharmaceutical Limited	Breakthrough Cancer Pain	12/21	12/21